Virtual Smoking Cessation Program Boosts Quit Rates for Cancer Patients

A recent study has found that a smoking cessation treatment program can significantly increase quit rates among cancer patients who smoke. The program, which was tested in community oncology care settings, combines virtual therapy with nicotine replacement medications to help patients overcome their addiction. Led by investigators from Mass General Brigham Cancer Institute and Memorial Sloan Kettering Cancer Center, the study was conducted as a randomized clinical trial for the ECOG-ACRIN Cancer Research Group.

The study's results, published in the Journal of Clinical Oncology, demonstrate the effectiveness of the treatment program. According to the findings, the intervention was well-received by patients and nearly doubled the quit rate at six months post-treatment. This is a significant outcome, as quitting smoking can greatly improve the health and well-being of cancer patients. The fact that the program was delivered in community oncology care settings also highlights the potential for widespread implementation and accessibility.

The study's conclusions underscore the importance of addressing smoking cessation in cancer care. By providing effective treatment programs, healthcare providers can help patients overcome nicotine addiction and reduce the risks associated with smoking. The success of this particular program suggests that similar interventions could be developed and implemented in other healthcare settings, ultimately leading to improved health outcomes for cancer patients who smoke.